What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in Q1 2020?

127 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 251,185,504
Total 13F shares: 122,545,605
Share change: -14,673,081
Total reported value: $245,076,906
Put/Call ratio: 14%
Price per share: $2.00
Number of holders: 127
Value change: -$37,929,778
Number of buys: 75
Number of sells: 61

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 09058V103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	4.8%	12,150,211	$41,918,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	4.4%	10,946,166	$37,764,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	4%	9,940,677	$34,295,000	—	31 Dec 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.7%	9,408,481	$32,459,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	3.3%	8,382,900	$28,921,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	3.2%	8,121,631	$28,020,000	—	31 Dec 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.5%	6,375,143	$21,994,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	2.4%	5,955,979	$20,548,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	2.2%	5,492,943	$18,951,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	2.2%	5,488,287	$18,935,000	—	31 Dec 2019	13F
Eversept Partners, LP	13F	Company	2%	4,904,460	$16,920,387	—	31 Dec 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.6%	4,000,000	$13,800,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	1.5%	3,803,254	$13,119,000	—	31 Dec 2019	13F
Ghost Tree Capital, LLC	13F	Company	1.2%	3,000,000	$10,350,000	—	31 Dec 2019	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.1%	2,825,000	$9,746,000	—	31 Dec 2019	13F
Woodline Partners LP	13F	Company	0.96%	2,417,829	$8,342,000	—	31 Dec 2019	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.87%	2,179,950	$7,521,000	—	31 Dec 2019	13F
Sofinnova Investments, Inc.	13F	Company	0.86%	2,151,164	$7,421,000	—	31 Dec 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.84%	2,116,417	$7,302,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.76%	1,910,404	$6,590,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.73%	1,830,432	$6,315,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.7%	1,758,840	$6,068,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.64%	1,602,315	$5,527,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.6%	1,501,812	$5,181,000	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.57%	1,425,455	$4,918,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.51%	1,286,541	$4,439,000	—	31 Dec 2019	13F
Parkman Healthcare Partners LLC	13F	Company	0.45%	1,141,212	$3,937,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.45%	1,123,279	$3,875,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.43%	1,068,498	$3,687,000	—	31 Dec 2019	13F
Maven Securities LTD	13F	Company	0.45%	1,118,593	$3,647,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.33%	840,734	$2,901,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	835,249	$2,882,000	—	31 Dec 2019	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.3%	749,200	$2,585,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.25%	618,943	$2,135,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.22%	543,801	$1,876,000	—	31 Dec 2019	13F
DAFNA Capital Management LLC	13F	Company	0.2%	514,051	$1,773,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.2%	509,067	$1,756,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.17%	422,162	$1,456,000	—	31 Dec 2019	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.16%	397,266	$1,370,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.15%	376,495	$1,299,000	—	31 Dec 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.13%	334,725	$1,154,000	—	31 Dec 2019	13F
Jefferies Group LLC	13F	Company	0.13%	315,000	$1,087,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.11%	284,000	$980,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	232,455	$802,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.09%	226,217	$780,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0.08%	199,515	$688,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.08%	199,404	$688,000	—	31 Dec 2019	13F
Spark Investment Management LLC	13F	Company	0.08%	192,479	$664,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.07%	184,169	$635,000	—	31 Dec 2019	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.07%	177,482	$612,000	—	31 Dec 2019	13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q1 2020

As of 31 Mar 2020, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,545,605 shares. The largest 10 holders included BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Eversept Partners, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, STATE STREET CORP, UBS Group AG, and JANUS HENDERSON GROUP PLC. This page lists 127 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

131

Q1 2020 holders

127

Holder diff

-4

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.